Received: from [184.22.128.125] (port=1671 helo=energy-oil-gas.com) by stodi.digitalkingdom.org with esmtp (Exim 4.76) (envelope-from ) id 1RW8yM-0005ok-7V for lojban@lojban.org; Thu, 01 Dec 2011 07:55:02 -0800 From: "Latest Cancer Vaccine" Subject: MNTR currently holds $2 per share in new cancer assets but trades at $0.24 per share To: lojban@lojban.org Content-Type: multipart/alternative; boundary="=_MoreStuf_2zzz1234sadvnqw3nerasdf" MIME-Version: 1.0 Date: Thu, 1 Dec 2011 09:54:57 -0600 Message-ID: <20111201095434.5960@energy-oil-gas.com> Content-Transfer-Encoding: 7bit X-CAMP: 154801 X-VALUE: 5960 X-Spam-Score: 3.7 (+++) X-Spam_score: 3.7 X-Spam_score_int: 37 X-Spam_bar: +++ X-Spam-Report: Spam detection software, running on the system "stodi.digitalkingdom.org", has identified this incoming email as possible spam. The original message has been attached to this so you can view it (if it isn't spam) or label similar future email. If you have any questions, see the administrator of that system for details. Content preview: View this email as Webpage Each $620 from MNTR Shareholders Pays for One More Month of Cancer Vaccine [...] Content analysis details: (3.7 points, 5.0 required) pts rule name description ---- ---------------------- -------------------------------------------------- -0.0 SPF_HELO_PASS SPF: HELO matches SPF record -0.0 SPF_PASS SPF: sender matches SPF record 1.7 URIBL_WS_SURBL Contains an URL listed in the WS SURBL blocklist [URIs: energy-oil-gas.com] 0.0 MIME_HTML_MOSTLY BODY: Multipart message mostly text/html MIME 0.0 HTML_MESSAGE BODY: HTML included in message 0.7 MPART_ALT_DIFF BODY: HTML and text parts are different 0.0 LOTS_OF_MONEY Huge... sums of money 1.3 RDNS_NONE Delivered to internal network by a host with no rDNS 0.0 T_REMOTE_IMAGE Message contains an external image This is a multi-part message in MIME format --=_MoreStuf_2zzz1234sadvnqw3nerasdf Content-Type: text/plain Content-Transfer-Encoding: 7bit --=_MoreStuf_2zzz1234sadvnqw3nerasdf Content-Type: text/html Content-Transfer-Encoding: 7bit

View this email as Webpage

 

 
 

Each $620 from MNTR Shareholders

Pays for One More Month of Cancer Vaccine 
 
Wednesday, November 30, 2011
 
Fellow Anti-Cancer Investor:     
 
MNTR currently holds $2 per share in new cancer assets and trades at $0.24 per share

Funds invested into Mentor Capital (Symbol: MNTR) are now being relayed forward to support melanoma trials at AGI Biopharmaceuticals, Ltd. Each $620 is needed to support one additional monthly cancer vaccine. 
128 vaccinated melanoma fighters have been holding back their cancers for 7 to 14 years.    With you, MNTR would like to bring this cancer vaccine out to the world.
$4.7 Million Acquisition vs. 2.3 Million Total MNTR Shares
 
MNTR recently received 30% of AGI Bio, a European biotech that produces the melanoma vaccine. In exchange, MNTR is funding the cancer trials and supporting final registration under a signed $4.7M financing agreement.
                                                              
Click below for the complete text of the AGI Bio press releases:
  
http://www.mentorcapital.com/Press-Releases.html
Our melanoma victims thank-you for joining MNTR in investing against cancer.
Chester Billingsley, CEO
Mentor Capital, Inc. (MNTR)
(760) 788 - 4700
 
Join Our Mailing List
 


To remove yourself from this distribution please click here to start the process for email deletion.

Stock Marketers Inc.
20 Royal Palm Way Boca Raton, FL 33441

--=_MoreStuf_2zzz1234sadvnqw3nerasdf--